Compare PARR & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PARR | PRGO |
|---|---|---|
| Founded | 1984 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2000 | 2013 |
| Metric | PARR | PRGO |
|---|---|---|
| Price | $60.99 | $9.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $50.60 | $19.33 |
| AVG Volume (30 Days) | 1.4M | ★ 3.7M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 12.02% |
| EPS Growth | ★ 1313.56 | N/A |
| EPS | ★ 7.16 | N/A |
| Revenue | ★ $2,443,066,000.00 | $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.98 | $1.02 |
| P/E Ratio | $8.09 | ★ N/A |
| Revenue Growth | ★ 30.99 | N/A |
| 52 Week Low | $12.04 | $9.23 |
| 52 Week High | $60.13 | $28.44 |
| Indicator | PARR | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 80.07 | 26.31 |
| Support Level | $34.55 | $9.23 |
| Resistance Level | N/A | $15.08 |
| Average True Range (ATR) | 2.84 | 0.51 |
| MACD | 1.00 | -0.08 |
| Stochastic Oscillator | 96.42 | 3.01 |
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.